Synapse

← Future Lipidology

Papers in Future Lipidology

Page 2 · newest first

  1. Pathways Involved In Lipid-Induced Insulin Resistance In ObesityFuture Lipidology · 2007
  2. Thyroid Hormone Receptor Subtype-β- Selective Agonists As Potential Treatments For Metabolic SyndromeFuture Lipidology · 2007
  3. Surgical Intervention For The Treatment Of Morbid Obesity And The DyslipidemiasFuture Lipidology · 2007
  4. Inhibiting Lipid Absorption Using Basic BiopolymersFuture Lipidology · 2007
  5. Sources Of Variability Of Plasma HDL-Cholesterol LevelsFuture Lipidology · 2007
  6. Mechanisms underlying fat-induced hepatic insulin resistaNceFuture Lipidology · 2007
  7. Inflammation, Dyslipidemia And Risks Of Ischemic Strokes In Systemic Lupus ErythematosusFuture Lipidology · 2007
  8. Potential Therapeutic Roles Of Lysophospholipid Signaling In Autoimmune-Related DiseaseFuture Lipidology · 2007
  9. Are Dietary Preferences Linked To Genes?Future Lipidology · 2007
  10. Long-Chain Acyl-Coa Synthetases And Fatty Acid ChannelingFuture Lipidology · 2007
  11. Lipid-Induced β-cell Dysfunction And Oxidative StressFuture Lipidology · 2007
  12. Role Of Lipids In Brain Injury And DiseasesFuture Lipidology · 2007
  13. Statins And Early Clinical Outcome After Coronary Artery Bypass GraftingFuture Lipidology · 2007
  14. Antisense Apolipoprotein B-100 As Novel Treatment For Hypercholesterolemia: Focus On Isis 301012Future Lipidology · 2007
  15. Heritability And Genetics Of Lipid MetabolismFuture Lipidology · 2007
  16. Cholesterol-Lowering Drugs And Alzheimer’S DiseaseFuture Lipidology · 2007
  17. Does Coffee Raise Cholesterol?Future Lipidology · 2007
  18. Niemann–Pick Type C Disease Proteins: Orphan Transporters Or Membrane Rheostats?Future Lipidology · 2007
  19. Lysophospholipids: Two-Faced Mediators In AtherosclerosisFuture Lipidology · 2007
  20. Omega-3 Fatty Acid Ethyl Esters (Omacor®) For The Treatment Of HypertriglyceridemiaFuture Lipidology · 2007
  21. Nutritional And Nutraceutical Considerations For DyslipidemiaFuture Lipidology · 2007
  22. Role Of Nuclear Plc And PI3K Signaling In The Development Of CancerFuture Lipidology · 2007
  23. Investigational Drugs Targeting HDL-C Metabolism And Reverse Cholesterol TransportFuture Lipidology · 2007
  24. Cardiovascular Disease Prevention And Markers Of HyperlipoproteinemiaFuture Lipidology · 2007
  25. Cholesterol And The Cerebral CirculationFuture Lipidology · 2007
  26. Pharmacotherapeutic Decisions In Menopausal Women With Cardiovascular RiskFuture Lipidology · 2007
  27. Regulation Of Hepatic Production Of Lipoproteins Containing Apolipoprotein B By ER-Associated DegradationFuture Lipidology · 2007
  28. Genetic Variations Of NPY And AGRP In Body Fatness RegulationFuture Lipidology · 2007
  29. Triacylglycerol Metabolism In Adipose TissueFuture Lipidology · 2007
  30. Rosuvastatin: The Most Efficient Treatment Option For Patients With DyslipidemiaFuture Lipidology · 2007
  31. Triglyceride-Rich Lipoproteins And Endothelial Dysfunction: Molecular Mechanisms And Gene Expression StudiesFuture Lipidology · 2007
  32. Alternate Approaches To Managing Lipid-Associated Cardiovascular RiskFuture Lipidology · 2007
  33. The RAGE Connection To Diabetes And Atherosclerosis: An Intertwined Web Of Advanced Glycation And InflammationFuture Lipidology · 2007
  34. Apolipoprotein A5: An Emerging Paradigm For Genetic Associations And Interactions In Lipoprotein And Cardiovascular ResearchFuture Lipidology · 2007
  35. Role Of Amphipathic α-Helical Structural Elements In Removing Cellular Cholesterol And Protecting Against Cardiovascular DiseaseFuture Lipidology · 2007
  36. Soy protein, soybean isoflavones and coronary heart disease risk: Where do we stand?Future Lipidology · 2007
  37. Structure–function relationships in human apolipoprotein A-I: role of a central helix pairFuture Lipidology · 2007
  38. Ceramide-1-phosphate, a new bioactive sphingolipid in regulating cell signalingFuture Lipidology · 2007
  39. Polyunsaturated fatty acids alter the rules of engagementFuture Lipidology · 2007
  40. OSBP-related proteins: lipid sensors or transporters?Future Lipidology · 2007
  41. PPARα: its role in the human metabolic syndromeFuture Lipidology · 2007
  42. Use Of statins in the ElderlyFuture Lipidology · 2007
  43. Phospholipid-mediated signaling in diseased myocardiumFuture Lipidology · 2006
  44. Effects of exercise on postprandial lipoprotein metabolismFuture Lipidology · 2006
  45. Phospholipase A₁: structure, distribution and functionFuture Lipidology · 2006
  46. Statins in diabetics, beyond cholesterol?Future Lipidology · 2006
  47. Fusogenic liposomes and their suitability for gene deliveryFuture Lipidology · 2006
  48. Dyslipidemia in HIV infectionFuture Lipidology · 2006
  49. Oxidized phospholipids at the interface of innate and adaptive immunityFuture Lipidology · 2006
  50. Unlocking the complexity of lipids: using lipidomics to identify disease mechanisms, biomarkers and treatment efficacyFuture Lipidology · 2006